Healthcare-Life-Sciences Market Reports

Comprehensive industry analysis, market size, and forecast for healthcare-life-sciences.

Showing 101 - 110 of 1045 reports

Nexletol Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.2 Billion Market Size 2034: USD 4.8 Billion CAGR: 14.8% Nexletol (bempedoic acid) is an oral, non-statin LDL-cholesterol-lowering therapy targeting ATP-citrate lyase, indicated for adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease requiring additional LDL reduction. It … Read More
Published August 2026

Omsk Hemorrhagic Fever Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 48.6 Million Market Size 2034: USD 89.3 Million CAGR: 6.3% Market Definition: The Omsk Hemorrhagic Fever (OHF) treatment market encompasses antiviral therapeutics, supportive care products, immun Read More
Published August 2026

Oculodentodigital Syndrome Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 185.4 million Market Size 2034: USD 412.7 million CAGR: 8.3% Market Definition: The oculodentodigital syndrome market encompasses diagnostics, therapeutics, and supportive care products targeting a rare autosomal dominant disorder caused by GJA1 gene mutations affecting ocular, dental, and digital … Read More
Published August 2026

Non-Radiographic Axial Spondyloarthritis Therapeutic Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 2.1 Billion Market Size 2034: USD 5.8 Billion CAGR: 10.7% Market Definition: The non-radiographic axial spondyloarthritis (nr-AxSpA) therapeutic market encompasses biologic and small-molecule treatments targeting patients with axial spondyloarthritis who show no definitive radiographic sacroiliac joint damage. It includes … Read More
Published August 2026

Niemann-Pick Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.2 Billion Market Size 2034: USD 3.8 Billion CAGR: 12.2% Market Definition: The Niemann-Pick disease market encompasses diagnostics, enzyme replacement therapies, substrate reduction therapies, and gene therapy pipelines targeting Types A, B, and C of this rare lysosomal storage … Read More
Published August 2026

S1P Receptor Modulator Drug Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 8.6 Billion Market Size 2034: USD 18.4 Billion CAGR: 7.9% S1P receptor modulator drugs are a class of sphingosine-1-phosphate receptor-targeting agents used primarily to manage relapsing forms of multiple sclerosis and inflammatory bowel disease by sequestering lymphocytes in lymph … Read More
Published August 2026

Mastocytosis Drug Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.42 Billion Market Size 2034: USD 3.87 Billion CAGR: 10.5% Market Definition: The mastocytosis drug market encompasses pharmaceutical therapies used to manage cutaneous and systemic mastocytosis, including mast cell stabilisers, tyrosine kinase inhibitors, and targeted biologics. It covers both … Read More
Published August 2026

Oncogene Inhibitor Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 18.6 billion Market Size 2034: USD 47.3 billion CAGR: 9.8% Market Definition: The oncogene inhibitor market encompasses small-molecule drugs, biologics, and targeted therapies designed to block the activity of mutated or overexpressed oncoproteins driving tumor growth. This includes kinase … Read More
Published August 2026

South Korea Necrotising Enterocolitis Market Size, Share & Forecast 2026–2034

Report Highlights Country: South Korea Market: Necrotising Enterocolitis Market Size 2024: USD 48.7 Million Market Size 2032: USD 91.4 Million CAGR: 8.2% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Probiotic Protocol Adoption Gap: Samsung Medical Center and Asan Medical … Read More
Published August 2026

UK Necrotising Enterocolitis Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 48.6 Million Market Size 2032: USD 89.3 Million CAGR: 7.9% Market Definition: The UK necrotising enterocolitis (NEC) market encompasses diagnostic tools, pharmaceutical treatments, surgical interventions, and nutritional therapies used in the prevention and management of NEC, a severe gastrointestinal … Read More
Published August 2026